[1] |
Simon DW, McGeachy MJ, Bayir H, et al. The far-reaching scope of neuroinflammation after traumatic brain injury[J]. Nat Rev Neurol, 2017, 13(3): 171-191.
|
[2] |
Shi K, Tian DC, Li ZG, et al. Global brain inflammation in stroke[J]. Lancet Neurol, 2019, 18(11): 1058-1066.
|
[3] |
Morganti-Kossmann MC, Semple BD, Hellewell SC, et al. The complexity of neuroinflammation consequent to traumatic brain injury: from research evidence to potential treatments[J]. Acta Neuropathol, 2019, 137(5): 731-755.
|
[4] |
Hu X, Leak RK, Thomson AW, et al. Promises and limitations of immune cell-based therapies in neurological disorders[J]. Nat Rev Neurol, 2018, 14(9): 559-568.
|
[5] |
Russo MV, McGavern DB. Inflammatory neuroprotection following traumatic brain injury[J]. Science, 2016, 353(6301): 783-785.
|
[6] |
Ritzel RM, Lai YJ, Crapser JD, et al. Aging alters the immunological response to ischemic stroke[J]. Acta Neuropathol, 2018, 136(1): 89-110.
|
[7] |
Chang CF, Goods BA, Askenase MH, et al. Erythrocyte efferocytosis modulates macrophages towards recovery after intracerebral hemorrhage[J]. J Clin Invest, 2018, 128(2): 607-624.
|
[8] |
Steinman L. Role reversal: infiltrating T cells protect the brain[J]. J Clin Invest, 2015, 125(2): 493-494.
|
[9] |
Dombrowski Y, O’Hagan T, Dittmer M, et al. Regulatory T cells promote myelin regeneration in the central nervous system[J]. Nat Neurosci, 2017, 20(5): 674-680.
|
[10] |
Skelly DT, Griffin EW, Murray CL, et al. Acute transient cognitive dysfunction and acute brain injury induced by systemic inflammation occur by dissociable IL-1-dependent mechanisms[J]. Mol Psychiatry, 2019, 24(10): 1533-1548.
|
[11] |
Lee JD, Coulthard LG, Woodruff TM. Complement dysregulation in the central nervous system during development and disease[J]. Semin Immunol, 2019, 45: 101340.
|
[12] |
Hammad A, Westacott L, Zaben M. Correction to: the role of the complement system in traumatic brain injury: a review[J]. J Neuroinflammation, 2018, 15(1): 59.
|
[13] |
Dabrowska S, Andrzejewska A, Lukomska B, et al. Neuroinflammation as a target for treatment of stroke using mesenchymal stem cells and extracellular vesicles[J]. J Neuroinflammation, 2019, 16(1): 178.
|
[14] |
Mathew B, Ravindran S, Liu X, et al. Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion[J]. Biomaterials, 2019, 197: 146-160.
|
[15] |
Reis M, Mavin E, Nicholson L, et al. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function[J]. Front Immunol, 2018, 9: 2538.
|
[16] |
Hotchkiss KM, Clark NM, Olivares-Navarrete R. Macrophage response to hydrophilic biomaterials regulates MSC recruitment and T-helper cell populations[J]. Biomaterials, 2018, 182: 202-215.
|
[17] |
Shi Y, Wang Y, Li Q, et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases[J]. Nat Rev Nephrol, 2018, 14(8): 493-507.
|
[18] |
Drommelschmidt K, Serdar M, Bendix I, et al. Mesenchymal stem cell-derived extracellular vesicles ameliorate inflammation-induced preterm brain injury[J]. Brain Behav Immun, 2017, 60: 220-232.
|
[19] |
Peruzzotti-Jametti L, Bernstock JD, Vicario N, et al. Macrophage-derived extracellular succinate licenses neural stem cells to suppress chronic neuroinflammation[J]. Cell Stem Cell, 2018, 22: 355-368.
|
[20] |
Kokaia Z, Martino G, Schwartz M, et al. Cross-talk between neural stem cells and immune cells: the key to better brain repair[J]. Nat Neurosci, 2012, 15(8): 1078-1087.
|
[21] |
Boese AC, Hamblin MH, Lee JP. Neural stem cell therapy for neurovascular injury in alzheimer’s disease[J]. Exp Neurol, 2020, 324: 113112.
|
[22] |
高谋,徐如祥,杨志军,等.两种干细胞对颅脑创伤炎症反应调控作用的对比研究[J].第三军医大学学报, 2015, 37(17): 1697-1703.
|
[23] |
Sheng C, Jungverdorben J, Wiethoff H, et al. A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation[J]. Nat Commun, 2018, 9: 4047.
|
[24] |
Kim SM, Flakamp H, Hermann A, et al. Direct conversion of mouse fibroblasts into induced neural stem cells[J]. Nat Protoc, 2014, 9(4): 871-881.
|
[25] |
Gao M, Yao H, Dong Q, et al. Neurotrophy and immunomodulation of induced neural stem cell grafts in a mouse model of closed head injury[J]. Stem Cell Res, 2017, 23: 132-142.
|
[26] |
Gao M, Dong Q, Yao H, et al. Induced neural stem cells modulate microglia activation states via CXCL12/CXCR4 signaling[J]. Brain Behav Immun, 2017, 59: 288-299.
|
[27] |
Gao M, Dong Q, Yao H, et al. Systemic administration of induced stem cells regulates complement activation in mouse closed head injury models[J]. Sci Rep, 2017, 7: 45989.
|
[28] |
Gao M, Dong Q, Lu Y, et al. Induced neural stem cell-derived astrocytes modulate complement activation and mediate neuroprotection following closed head injury[J]. Cell Death Dis, 2018, 9(2): 101.
|
[29] |
Carney N, Totten AM, O’reilly C, et al. Guidelines for the management of severe traumatic brain injury[J]. Neurosurgery, 2017, 80(1): 6-15.
|
[30] |
Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges[J]. Cell Stem Cell, 2015, 17(1): 11-22.
|